{"id":1997,"date":"2026-05-13T12:00:58","date_gmt":"2026-05-13T12:00:58","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/05\/13\/2-common-ms-treatments-show-equal-benefit-in-late-onset-disease\/"},"modified":"2026-05-13T12:00:58","modified_gmt":"2026-05-13T12:00:58","slug":"2-common-ms-treatments-show-equal-benefit-in-late-onset-disease","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/05\/13\/2-common-ms-treatments-show-equal-benefit-in-late-onset-disease\/","title":{"rendered":"2 common MS treatments show equal benefit in late-onset disease"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/05\/13\/2-common-ms-treatments-show-equal-benefit-late-onset-disease\/\" title=\"2 common MS treatments show equal benefit in late-onset disease\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"533\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2026\/04\/iStock-2263497676-800x533.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"A photo shows a balance scale.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"161296\" \/><\/a><\/p>\n<p>Two commonly used disease-modifying treatments\u00a0seem to be equally effective for most people with late-onset multiple sclerosis (LOMS), according to a real-world analysis. Anti-CD20 therapies, designed to reduce immune cells that produce disease-driving antibodies, and S1P receptor modulators, which work by preventing pro-inflammatory immune cells from reaching the brain, showed similar benefits across measures of disease [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/05\/13\/2-common-ms-treatments-show-equal-benefit-late-onset-disease\/\">2 common MS treatments show equal benefit in late-onset disease<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/05\/13\/2-common-ms-treatments-show-equal-benefit-late-onset-disease\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Two commonly used disease-modifying treatments\u00a0seem to be equally effective for most people with late-onset multiple sclerosis (LOMS), according to a real-world analysis. Anti-CD20 therapies, designed to reduce immune cells that produce disease-driving antibodies, and S1P receptor modulators, which work by preventing pro-inflammatory immune cells from&hellip;<\/p>\n","protected":false},"author":0,"featured_media":1998,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-1997","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1997","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=1997"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1997\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/1998"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=1997"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=1997"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=1997"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}